These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26566163)

  • 1. Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis.
    Jonas MM; Lok AS; McMahon BJ; Brown RS; Wong JB; Ahmed AT; Farah W; Mouchli MA; Singh S; Prokop LJ; Murad MH; Mohammed K
    Hepatology; 2016 Jan; 63(1):307-18. PubMed ID: 26566163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
    Lin ZQ; Fang F; Guo ZF; Chen Q
    Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.
    Shamliyan TA; MacDonald R; Shaukat A; Taylor BC; Yuan JM; Johnson JR; Tacklind J; Rutks I; Kane RL; Wilt TJ
    Ann Intern Med; 2009 Jan; 150(2):111-24. PubMed ID: 19124812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis.
    Xie QL; Zhu Y; Wu LH; Fu LL; Xiang Y
    PLoS One; 2015; 10(7):e0132219. PubMed ID: 26226455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Telbivudine Versus Other Nucleos(t)ide Analogs on HBeAg Seroconversion and Other Outcomes in Patients with Chronic Hepatitis B: A Network Meta-Analysis.
    Liang X; Fan R; Sun J; Shaikh J; Taneja A; Gupta S; Hamed K
    Adv Ther; 2016 Apr; 33(4):519-31. PubMed ID: 26921204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Better Antiviral Efficacy Found in Nucleos(t)ide Analog (NA) Combinations with Interferon Therapy than NA Monotherapy for HBeAg Positive Chronic Hepatitis B: A Meta-Analysis.
    Wei W; Wu Q; Zhou J; Kong Y; You H
    Int J Environ Res Public Health; 2015 Aug; 12(8):10039-55. PubMed ID: 26308024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.
    Yuan Y; Iloeje UH; Hay J; Saab S
    J Manag Care Pharm; 2008; 14(1):21-33. PubMed ID: 18240879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
    Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU
    Clin Mol Hepatol; 2014 Dec; 20(4):355-60. PubMed ID: 25548741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolonged duration of the routine pegylated-interferon alfa-2a therapy produces superior virological response in HBeAg-positive chronic hepatitis B patients: a single-center cohort study].
    Zhu YY; Wu YL; Chen J; Zheng Q; Dong J; Jiang JJ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):737-41. PubMed ID: 23207332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between hepatitis B virus genotype B and C and response to interferon therapy in HBeAg positive chronic hepatitis B patients: A meta-analysis.
    Kong LN; Qin B; Ma Q; Li L; Yao Y
    J Gastroenterol Hepatol; 2014; 29(7):1387-95. PubMed ID: 24548048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Blazina I; Bougatsos C; Holmes R; Selph S; Grusing S; Jou J
    JAMA; 2020 Dec; 324(23):2423-2436. PubMed ID: 33320229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entecavir versus lamivudine for the treatment of chronic hepatitis B: a systematic review.
    Liang J; Tang YF; Wu FS; Deng X
    Pharmazie; 2012 Nov; 67(11):883-90. PubMed ID: 23210236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials.
    Wong WWL; Pechivanoglou P; Wong J; Bielecki JM; Haines A; Erman A; Saeed Y; Phoon A; Tadrous M; Younis M; Rayad NZ; Rac V; Janssen HLA; Krahn MD
    Syst Rev; 2019 Aug; 8(1):207. PubMed ID: 31426837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.
    Brown RS; McMahon BJ; Lok AS; Wong JB; Ahmed AT; Mouchli MA; Wang Z; Prokop LJ; Murad MH; Mohammed K
    Hepatology; 2016 Jan; 63(1):319-33. PubMed ID: 26565396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study.
    Liang J; Jiang MJ; Deng X; Xiao Zhou X
    Hepat Mon; 2013; 13(6):e7862. PubMed ID: 24032045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.
    Wong RJ; Nguyen MT; Trinh HN; Chan C; Huynh A; Ly MT; Nguyen HA; Nguyen KK; Torres S; Yang J; Liu B; Garcia RT; Bhuket T; Baden R; Levitt B; da Silveira E; Gish RG
    J Viral Hepat; 2017 Dec; 24(12):1089-1097. PubMed ID: 28581644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood.
    Wu JF; Chiu YC; Chang KC; Chen HL; Ni YH; Hsu HY; Chang MH
    Hepatology; 2016 Jan; 63(1):74-82. PubMed ID: 26389515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.